Market Exclusive

Analyst Activity – Leerink Swann Lowers Its Price Target On Celldex Therapeutics (NASDAQ:CLDX) to $3.00

Analyst Ratings For Celldex Therapeutics (NASDAQ:CLDX)

Today, Leerink Swann lowered its price target on Celldex Therapeutics (NASDAQ:CLDX) to $3.00 per share.

Some recent analyst ratings include

Recent Insider Trading Activity For Celldex Therapeutics (NASDAQ:CLDX)
Celldex Therapeutics (NASDAQ:CLDX) has insider ownership of 4.10% and institutional ownership of 57.55%.

Recent Trading Activity for Celldex Therapeutics (NASDAQ:CLDX)
Shares of Celldex Therapeutics closed the previous trading session at 2.78 up +0.31 12.35% with 2.4600000381469727 shares trading hands.

Exit mobile version